Katherine High is a pioneering gene therapy scientist and the CEO of RhyGaze. She co-founded Spark Therapeutics, where she led the development of the first FDA-approved gene therapy for a genetic disease. She earned her BA from Harvard University and her MD from the UNC School of Medicine.
Outside of her extensive scientific career, Katherine is an avid reader with a deep interest in the history of science and medicine. She has mentioned in interviews that she owns a farm, suggesting a connection to life beyond the laboratory and boardroom.
Katherine was the co-recipient of the inaugural $1 million Sanford Lorraine Cross Award for Medical Innovation for her groundbreaking work.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.